Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-555739 in nasal allergen challenge for intermittent grass pollen allergic rhinitis
2008-006788-35Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of asapiprant in allergic rhinitis (AR) (2 arms), sponsored by Shionogi & Co., Ltd. Started Nov 2008; status: completed.
02
Drugs
asapiprant
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2008-006788-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006788-35.